BioWorld MedTech

Dec. 9, 2013

View Archived Issues

Boston Sci has favorable results for Precision Spectra SCS study

A study evaluating Boston Scientific's (Natick, Massachusetts) Precision Spectra Spinal Cord Stimulator (SCS), shows that the device provides highly significant pain relief three months after implantation. Read More

Life science VC funding seen falling behind overall funding growth rates

Read More

BSD begins selling MicroThermX microwave ablation in Turkey

Read More

Financings roundup: Physicians Trust prices 8.3M shares, seeks to raise more than $89 million

Read More

Grants roundup: QED program grants $600,000 to support four new technologies

Read More

Agreements/contracts: Boston Sci, Medicines Co. co-promote Premier stent

Read More

Med-tech Notes

Read More

Product briefs

Read More

MDD's Neurology Extra

Read More